South Korea
· Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 133.61 billion. The enterprise value is 138.37 billion.
| Market Cap | 133.61B |
| Enterprise Value | 138.37B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 11.74% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +11.74% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 20.07% |
| Owned by Institutions (%) | 7.90% |
| Float | 16.02M |
Valuation Ratios
The trailing PE ratio is 20.77.
| PE Ratio | 20.77 |
| Forward PE | n/a |
| PS Ratio | 3.70 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 25.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.18, with an EV/FCF ratio of -228.02.
| EV / Earnings | 21.72 |
| EV / Sales | 3.84 |
| EV / EBITDA | 16.18 |
| EV / EBIT | 27.58 |
| EV / FCF | -228.02 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.92 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 2.53 |
| Debt / FCF | -35.59 |
| Interest Coverage | 4.61 |
Financial Efficiency
Return on equity (ROE) is 11.28% and return on invested capital (ROIC) is 4.15%.
| Return on Equity (ROE) | 11.28% |
| Return on Assets (ROA) | 3.66% |
| Return on Invested Capital (ROIC) | 4.15% |
| Return on Capital Employed (ROCE) | 6.73% |
| Revenue Per Employee | 194.97M |
| Profits Per Employee | 34.44M |
| Employee Count | 185 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, OSTEONIC has paid 1.23 billion in taxes.
| Income Tax | 1.23B |
| Effective Tax Rate | 16.18% |
Stock Price Statistics
The stock price has increased by +38.06% in the last 52 weeks. The beta is 1.07, so OSTEONIC's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +38.06% |
| 50-Day Moving Average | 6,713.40 |
| 200-Day Moving Average | 6,433.03 |
| Relative Strength Index (RSI) | 48.77 |
| Average Volume (20 Days) | 216,387 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 36.07 billion and earned 6.37 billion in profits. Earnings per share was 320.63.
| Revenue | 36.07B |
| Gross Profit | 17.77B |
| Operating Income | 5.02B |
| Pretax Income | 7.60B |
| Net Income | 6.37B |
| EBITDA | 8.55B |
| EBIT | 5.02B |
| Earnings Per Share (EPS) | 320.63 |
Balance Sheet
The company has 16.84 billion in cash and 21.60 billion in debt, giving a net cash position of -4.76 billion or -237.26 per share.
| Cash & Cash Equivalents | 16.84B |
| Total Debt | 21.60B |
| Net Cash | -4.76B |
| Net Cash Per Share | -237.26 |
| Equity (Book Value) | 60.96B |
| Book Value Per Share | 3,038.49 |
| Working Capital | 34.00B |
Cash Flow
In the last 12 months, operating cash flow was 5.20 billion and capital expenditures -5.80 billion, giving a free cash flow of -606.81 million.
| Operating Cash Flow | 5.20B |
| Capital Expenditures | -5.80B |
| Free Cash Flow | -606.81M |
| FCF Per Share | -30.25 |
Margins
Gross margin is 49.27%, with operating and profit margins of 13.91% and 17.66%.
| Gross Margin | 49.27% |
| Operating Margin | 13.91% |
| Pretax Margin | 21.07% |
| Profit Margin | 17.66% |
| EBITDA Margin | 23.71% |
| EBIT Margin | 13.91% |
| FCF Margin | n/a |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.74% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.77% |
| FCF Yield | -0.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.07 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.07 |
| Piotroski F-Score | 5 |